跳至主要内容
临床试验/NCT03764514
NCT03764514已完成不适用

Effectiveness of Spinal Cord Stimulation as Therapy for Chemotherapy-Induced Peripheral Neuropathy: A Pilot Trial

Prisma Health-Upstate1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2018年12月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
1
主要终点
Permanent Spinal Cord Stimulator Implantation

研究概览

简要总结

This is an observational based pilot study evaluating the use of spinal cord stimulators for the treatment of chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and decrease in pain.

详细描述

Cancer treatment, for many patients, results in painful side effects. As evidence mounts demonstrating the risks associated with long term opioid therapy, non-opioid modalities need to be developed. Spinal cord stimulators are implanted devices that modulate the pain signaling system in the spinal cord. This research hopes to determine if the use of a spinal cord stimulator in patients with chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and decrease in pain.The primary endpoints will be the number of patients who undergo permanent implantation. The endpoints will measure pain with the Brief Pain Inventory Short Form visual analog scale. The sleep quality will be measured using the Pittsburgh Sleep Quality Assessment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient has persistent, severe peripheral neuropathy secondary to chemotherapy

排除标准

  • Refusal to undergo a spinal cord stimulator procedure

结局指标

主要结局

Permanent Spinal Cord Stimulator Implantation

时间窗: 2 years

To determine the total number of patients who undergo permanent spinal cord stimulator implantation.

次要结局

  • Subjective Quality of Life Assessment: Pittsburgh Sleep Quality Assessment(2 years)
  • Subjective Pain Assessment: Brief Pain Inventory-Short Form(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验